BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35411033)

  • 1. Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.
    Bramhecha YM; Guérard KP; Audet-Walsh É; Rouzbeh S; Kassem O; Pernet E; Scarlata E; Hamel L; Brimo F; Divangahi M; Aprikian AG; Chevalier S; Giguère V; Lapointe J
    Oncogene; 2022 May; 41(20):2798-2810. PubMed ID: 35411033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal Delta3-cis-Delta2-trans-enoyl-CoA isomerase encoded by ECI1 is required for growth of the yeast Saccharomyces cerevisiae on unsaturated fatty acids.
    Gurvitz A; Mursula AM; Firzinger A; Hamilton B; Kilpeläinen SH; Hartig A; Ruis H; Hiltunen JK; Rottensteiner H
    J Biol Chem; 1998 Nov; 273(47):31366-74. PubMed ID: 9813046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of Saccharomyces cerevisiae Delta3, Delta2-enoyl-CoA isomerase.
    Geisbrecht BV; Zhu D; Schulz K; Nau K; Morrell JC; Geraghty M; Schulz H; Erdmann R; Gould SJ
    J Biol Chem; 1998 Dec; 273(50):33184-91. PubMed ID: 9837886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids.
    van Weeghel M; te Brinke H; van Lenthe H; Kulik W; Minkler PE; Stoll MS; Sass JO; Janssen U; Stoffel W; Schwab KO; Wanders RJ; Hoppel CL; Houten SM
    FASEB J; 2012 Oct; 26(10):4316-26. PubMed ID: 22782973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
    Bramhecha YM; Rouzbeh S; Guérard KP; Scarlata E; Brimo F; Chevalier S; Hamel L; Aprikian AG; Lapointe J
    Mod Pathol; 2019 Jan; 32(1):128-138. PubMed ID: 30140035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.
    Bramhecha YM; Guérard KP; Rouzbeh S; Scarlata E; Brimo F; Chevalier S; Hamel L; Dragomir A; Aprikian AG; Lapointe J
    Mol Cancer Res; 2018 Jan; 16(1):115-123. PubMed ID: 28993510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of Delta3,Delta2-enoyl-CoA isomerases from rat liver.
    Zhang D; Yu W; Geisbrecht BV; Gould SJ; Sprecher H; Schulz H
    J Biol Chem; 2002 Mar; 277(11):9127-32. PubMed ID: 11781327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.
    Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
    Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
    Zhang L; Guo F; Gao X; Wu Y
    Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta3,5,7,Delta2,4,6-trienoyl-CoA isomerase, a novel enzyme that functions in the beta-oxidation of polyunsaturated fatty acids with conjugated double bonds.
    Liang X; Zhu D; Schulz H
    J Biol Chem; 1999 May; 274(20):13830-5. PubMed ID: 10318788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of mitochondrial beta -oxidation of unsaturated fatty acids in the 3,2-trans-enoyl-CoA isomerase-deficient mouse.
    Janssen U; Stoffel W
    J Biol Chem; 2002 May; 277(22):19579-84. PubMed ID: 11916962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.
    Wan S; Xi M; Zhao HB; Hua W; Liu YL; Zhou YL; Zhuo YJ; Liu ZZ; Cai ZD; Wan YP; Zhong WD
    Pathol Res Pract; 2019 Aug; 215(8):152464. PubMed ID: 31176575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of Eci3, a murine kidney-specific Δ3,Δ2-enoyl-CoA isomerase.
    van Weeghel M; Ofman R; Argmann CA; Ruiter JP; Claessen N; Oussoren SV; Wanders RJ; Aten J; Houten SM
    FASEB J; 2014 Mar; 28(3):1365-74. PubMed ID: 24344334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial 3-2trans-Enoyl-CoA isomerase. Purification, cloning, expression, and mitochondrial import of the key enzyme of unsaturated fatty acid beta-oxidation.
    Müller-Newen G; Stoffel W
    Biol Chem Hoppe Seyler; 1991 Aug; 372(8):613-24. PubMed ID: 1958319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of Lys242 allows Delta3-Delta2-enoyl-CoA isomerase to acquire enoyl-CoA hydratase activity.
    Yu W; Chu X; Deng G; Liu X; Chen G; Li D
    Biochim Biophys Acta; 2006 Dec; 1760(12):1874-83. PubMed ID: 16952422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.